: The emergence and spread of chloroquine resistant (CQR) strains of Plasmodium falciparum, first reported in Asia and South America, drastically compromises efforts to treat and control malaria. Chloroquine (CQ) interferes with the process of heme polymerization in the parasite digestive vacuole (DV) and chloroquine resistance (CQR) is associated with reduced accumulation of this drug. Our long-term objective is to understand CQR at the genetic and physiological level. Recent work has led to the identification of the pfcrt (P. falciparum chloroquine resistance transporter) gene, which encodes the DV transmembrane protein PfCRT. Mutations in pfcrt segregate with the verapamil (VP)-reversible CQR phenotype in a genetic cross and show a strong association with CQR in laboratory-adapted field isolates. These data and CQ selection experiments implicate a central role for pfcrt mutations in CQR. This now raises the critical question of whether CQR results from mutations in this gene alone or whether multiple genes are necessary for this phenotype. Significant insight into the CQR mechanism can also now be gained by defining the physiological function(s) of PfCRT. The first specific aim of this application is to assess the contribution of individual pfcrt mutations to CQR. Chloroquine-sensitive (CQS) and chloroquine-resistant (CQR) P. falciparum lines will be transformed with episomal transgene constructs that express pfcrt sequences from CQR and CQS parasites and transformed lines will be assayed for changes in parasite response to CQ+/-VP. These assays provide a rapid screen to identify key pfcrt mutations involved in CQR. The second specific aim will determine by allelic exchange whether pfcrt mutations are necessary and sufficient to confer P. falciparum CQR in both New and Old World strains. The third specific aim will determine the physiological function of PfCRT and how this relates mechanistically to CQR. Single-cell pH measurements on pfcrf-modified lines will be performed to test the model that pfcrt mutations can cause CQR by acidification of the DV pH. pfcrt sequences will be expressed in Xenopus laevis oocytes to assess for transport of CQ and candidate physiological substrates. These studies will yield data that should stimulate new strategies to counter the spread of CQR malaria and contribute significantly to understanding the molecular and physiological basis of CQR.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI050234-03
Application #
6632493
Study Section
Tropical Medicine and Parasitology Study Section (TMP)
Program Officer
Coyne, Philip Edward
Project Start
2001-08-01
Project End
2006-05-31
Budget Start
2003-06-01
Budget End
2004-05-31
Support Year
3
Fiscal Year
2003
Total Cost
$375,844
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
071036636
City
Bronx
State
NY
Country
United States
Zip Code
10461
Cowell, Annie N; Istvan, Eva S; Lukens, Amanda K et al. (2018) Mapping the malaria parasite druggable genome by using in vitro evolution and chemogenomics. Science 359:191-199
Ross, Leila S; Dhingra, Satish K; Mok, Sachel et al. (2018) Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine. Nat Commun 9:3314
Schuh, Anna Katharina; Rahbari, Mahsa; Heimsch, Kim C et al. (2018) Stable Integration and Comparison of hGrx1-roGFP2 and sfroGFP2 Redox Probes in the Malaria Parasite Plasmodium falciparum. ACS Infect Dis 4:1601-1612
Lee, Andrew H; Dhingra, Satish K; Lewis, Ian A et al. (2018) Evidence for Regulation of Hemoglobin Metabolism and Intracellular Ionic Flux by the Plasmodium falciparum Chloroquine Resistance Transporter. Sci Rep 8:13578
Agrawal, Sonia; Moser, Kara A; Morton, Lindsay et al. (2017) Association of a Novel Mutation in the Plasmodium falciparum Chloroquine Resistance Transporter With Decreased Piperaquine Sensitivity. J Infect Dis 216:468-476
Vanaerschot, Manu; Lucantoni, Leonardo; Li, Tao et al. (2017) Hexahydroquinolines are antimalarial candidates with potent blood-stage and transmission-blocking activity. Nat Microbiol 2:1403-1414
Rahbari, Mahsa; Rahlfs, Stefan; Przyborski, Jude M et al. (2017) Hydrogen peroxide dynamics in subcellular compartments of malaria parasites using genetically encoded redox probes. Sci Rep 7:10449
Blasco, Benjamin; Leroy, Didier; Fidock, David A (2017) Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic. Nat Med 23:917-928
Dhingra, Satish K; Redhi, Devasha; Combrinck, Jill M et al. (2017) A Variant PfCRT Isoform Can Contribute to Plasmodium falciparum Resistance to the First-Line Partner Drug Piperaquine. MBio 8:
Gabryszewski, Stanislaw J; Dhingra, Satish K; Combrinck, Jill M et al. (2016) Evolution of Fitness Cost-Neutral Mutant PfCRT Conferring P. falciparum 4-Aminoquinoline Drug Resistance Is Accompanied by Altered Parasite Metabolism and Digestive Vacuole Physiology. PLoS Pathog 12:e1005976

Showing the most recent 10 out of 51 publications